Participate in migraines Clinical Trial Today

Upcoming trials

  • The ASTRALS Study is a Phase 2 study using VHB937 for those with Amyotrophic Lateral Sclerosis. Approximately 225 participants are expected to take part in North America and Europe.

    For more information, please visit clinicaltrials.gov.

    If you are interested in participating, please contact Yousri YBenchaar@gengepartners.com

  • More information soon!

  • More information coming soon!

If you would like to hear about more about our current or upcoming neurological clinical trials in Montreal please contact us at: info@gengepartners.com

“If we’re not in the beginning for rare disease, we may simply be too late for our patients to get the benefit of these new therapies.”

-Angela Genge

  • Our mission

    To improve patient health and well-being by conducting cutting-edge clinical research. We strive to foster a culture of innovation, collaboration, and excellence in all aspects of our research, and to contribute to the global effort to improve healthcare for all.

  • Our vision

    To be a leading force in advancing medical knowledge and improving patient care through innovative and ethical clinical research

  • Our future

    Genge Partners will continue to be at the forefront of clinical research, utilizing the latest technologies and methodologies to bring new treatments and therapies to patients in need. Our commitment to patient safety, scientific rigor, and ethical conduct will remain steadfast, as we work to improve healthcare for all and make a lasting impact on the field of medicine.

Our facility:

Genge Partners @ Glen
5100 Boul. de Maisonneuve Ouest, 6th floor
Montreal, QC H4A 3TA

 

© 2022 Genge Partners Inc. All rights reserved | Confidentiality policy